Report cover image

Lipid Nanoparticles Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Oct 01, 2024
Length 98 Pages
SKU # FOB19224188

Description

Lipid Nanoparticles Market



Growth Factors of Lipid Nanoparticles Market

The lipid nanoparticles market size was valued at USD 880.0 million in 2023, and the market is now projected to grow from USD 997.2 million in 2024 to USD 2823.4 million by 2032, exhibiting a CAGR of 13.9% during the forecast period of 2024-2032.

The market also witnessed fair share of revenue growth in the year 2020, mainly contributed by the increasing usage of Lipid Nanoparticles (LNPs) for vaccines’ delivery. These nanoparticles help in delivery of delicate mRNA used in COVID-19 vaccines into human cells to facilitate gene therapies. Pfizer and Moderna employ LNPs in their mRNA COVID-19 vaccines launched on the market. It is for this reason that the demand for LNPs has risen with pharma companies leveraging them in the pharmaceutical sector.

Site-specific drug delivery systems remain imperative in personalized medicines about improving treatment outcomes. LPN along with liposome and niosomes are used in different therapeutic segments, for example oncology and neurology. Nanotechnology based drug delivery system enhances the selectivity of the administered drug to deliver the therapy to the required site successfully. Its application is relevant for the development of personalized medicine approaches.

Lipid nanoparticles are ideal in gene therapy for diseases of genetic origin since they are much safer than viral proteins. It can bring nucleic acids of any sort into the cells with improved therapeutical options. Also, their synthesis is cost effective and fast owing to the convenience of targeting ligands that enable selective targeting in gene delivery applications. This capability greatly enhances the possibility of genetic approaches to therapy.

Comprehensive Analysis of Lipid Nanoparticles Market

The lipid nanoparticles market growth is rising at an exponential rate due to its market segmentation. This market expansion rightly presents a detailed local analysis based on the forces such as supply and demand which define the industry. These segmentations are methodically segregated by type analysis, by application analysis and by end-user analysis. By type analysis include Solid Lipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), others. By application analysis include therapeutics, research. By end-user analysis include pharmaceutical & biotechnology companies, academic & research Institutes, others.

The North America region lead the lipid nanoparticles market share by benefitting a market size of USD 577.7 million in 2023 due to robust presence of the major players.

The top players have a significant responsibility in the healthcare industry for confirming industrial prospectus growth and determining the market trends. These players include, Merck KGaA, Evonik Industries AG, Gattefossé, Precision NanoSystems, IOI Oleo GmbH these market players provide a level-playing competitive landscape.

In July 2023, Cytiva launched NanoAssemblr, a specialized system for the clinical and commercial production of lipid nanoparticle medicines.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 13.9% from 2024-2032

Unit Value (USD Million)

Segmentation By Type
  • Solid Lipid Nanoparticles (SLNs)
  • Nanostructured Lipid Carriers (NLCs)
  • Others
By Application
  • Therapeutics
  • Research
By End-user
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
By Geography
  • North America (By Type, By Application, By End-user, and By Country)
  • U.S.
  • Canada
  • Europe (By Type, By Application, By End-user, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
  • Asia Pacific (By Type, By Application, By End-user, and By Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
  • Rest of the World (By Type, By Application, and By End-user)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

98 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. New Product Launches, By Key Players
4.2. Key Industry Developments- Mergers, Acquisitions & Partnerships
4.3. Recent Advances in Drug Delivery Using Lipid Nanoparticles
4.4. Impact of COVID-19 on the Market
5. Global Lipid Nanoparticles Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Solid Lipid Nanoparticles (SLNs)
5.1.2. Nanostructured Lipid Carriers (NLCs)
5.1.3. Others
5.2. Market Analysis, Insights and Forecast – By Application
5.2.1. Therapeutics
5.2.2. Research
5.3. Market Analysis, Insights and Forecast – By End-user
5.3.1. Pharmaceutical & Biotechnology Companies
5.3.2. Academic & Research Institutes
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Rest of the World
6. North America Lipid Nanoparticles Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Solid Lipid Nanoparticles (SLNs)
6.1.2. Nanostructured Lipid Carriers (NLCs)
6.1.3. Others
6.2. Market Analysis, Insights and Forecast – By Application
6.2.1. Therapeutics
6.2.2. Research
6.3. Market Analysis, Insights and Forecast – By End-user
6.3.1. Pharmaceutical & Biotechnology Companies
6.3.2. Academic & Research Institutes
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Lipid Nanoparticles Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Solid Lipid Nanoparticles (SLNs)
7.1.2. Nanostructured Lipid Carriers (NLCs)
7.1.3. Others
7.2. Market Analysis, Insights and Forecast – By Application
7.2.1. Therapeutics
7.2.2. Research
7.3. Market Analysis, Insights and Forecast – By End-user
7.3.1. Pharmaceutical & Biotechnology Companies
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific Lipid Nanoparticles Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Solid Lipid Nanoparticles (SLNs)
8.1.2. Nanostructured Lipid Carriers (NLCs)
8.1.3. Others
8.2. Market Analysis, Insights and Forecast – By Application
8.2.1. Therapeutics
8.2.2. Research
8.3. Market Analysis, Insights and Forecast – By End-user
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Academic & Research Institutes
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Rest of the World Lipid Nanoparticles Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Solid Lipid Nanoparticles (SLNs)
9.1.2. Nanostructured Lipid Carriers (NLCs)
9.1.3. Others
9.2. Market Analysis, Insights and Forecast – By Application
9.2.1. Therapeutics
9.2.2. Research
9.3. Market Analysis, Insights and Forecast – By End-user
9.3.1. Pharmaceutical & Biotechnology Companies
9.3.2. Academic & Research Institutes
9.3.3. Others
10. Competitive Analysis
10.1. Global Market Share Analysis (2023)
10.2. Company Profiles
10.2.1. Merck KGaA
10.2.1.1. Overview
10.2.1.2. Products & Services
10.2.1.3. SWOT Analysis
10.2.1.4. Recent Developments
10.2.1.5. Strategies
10.2.1.6. Financials (Based on Availability)
10.2.2. Evonik Industries AGS
10.2.2.1. Overview
10.2.2.2. Products & Services
10.2.2.3. SWOT Analysis
10.2.2.4. Recent Developments
10.2.2.5. Strategies
10.2.2.6. Financials (Based on Availability)
10.2.3. Gattefossé
10.2.3.1. Overview
10.2.3.2. Products & Services
10.2.3.3. SWOT Analysis
10.2.3.4. Recent Developments
10.2.3.5. Strategies
10.2.3.6. Financials (Based on Availability)
10.2.4. Precision NanoSystems
10.2.4.1. Overview
10.2.4.2. Products & Services
10.2.4.3. SWOT Analysis
10.2.4.4. Recent Developments
10.2.4.5. Strategies
10.2.4.6. Financials (Based on Availability)
10.2.5. IOI Oleo GmbH
10.2.5.1. Overview
10.2.5.2. Products & Services
10.2.5.3. SWOT Analysis
10.2.5.4. Recent Developments
10.2.5.5. Strategies
10.2.5.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us